Jump to content

Novel Njweipi Chegou

Edit links
From Wikipedia, the free encyclopedia
Novel Njweipi Chegou
Born
Cameroon
Alma materStellenbosch University
University of Buea
Scientific career
InstitutionsStellenbosch University

Novel Njweipi Chegou is a Cameroonian molecular biologist who is a professor at the Stellenbosch University Immunology Research Group. His research considers pulmonary and extrapulmonary tuberculosis. He leads the Diagnostics Research Laboratory. He was awarded the Royal Society Africa Prize in 2022.

Early life and education

Chegou is from the Anglophone region of Cameroon.[1] He studied medical sciences at the University of Buea and then started a degree in health sciences at Stellenbosch University. His master's research considered the immunology of tuberculosis, and he continued in the field for his doctoral research.[1] His doctoral research identified and patented a QuantiFERON supernatant biosignature that can differentiate between active and latent Mycobacterium tuberculosis.[1]

Research and career

Chegou looks to develop a testing platform for tuberculosis.[2] He has investigated different biomarkers of tuberculosis, and developed a strategy to identify tuberculosis meningitis in children and in places with limited access to resources, such as rural areas.[1]

Awards and honours

  • 2015 Stellenbosch University Rector's Award[3]
  • 2015 UNESCO-MARS award[4]
  • 2019 South African Medical Research Council Silver award[5][6][7]
  • 2019 NSTF-South32 Awards[8]
  • 2022 Royal Society Africa Prize[9][3]

Selected publications

  • Daniel E Zak; Adam Penn-Nicholson; Thomas J Scriba; et al. (23 March 2016). "A blood RNA signature for tuberculosis disease risk: a prospective cohort study". The Lancet. 387 (10035): 2312–2322. doi:10.1016/S0140-6736(15)01316-1. ISSN 0140-6736. PMC 5392204. PMID 27017310. Wikidata Q33566308.{{cite journal}}: CS1 maint: numeric names: authors list (link)
  • Gerhard Walzl; Ruth McNerney; Nelita Du Plessis; Matthew Bates; Timothy D McHugh; Novel N Chegou; Alimuddin Zumla (23 March 2018). "Tuberculosis: advances and challenges in development of new diagnostics and biomarkers". Lancet Infectious Diseases. 18 (7): e199–e210. doi:10.1016/S1473-3099(18)30111-7. ISSN 1473-3099. PMID 29580818. Wikidata Q52629916.
  • Novel N Chegou; Gillian F Black; Martin Kidd; Paul D van Helden; Gerhard Walzl (16 May 2009). "Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report". BMC Pulmonary Medicine. 9: 21. doi:10.1186/1471-2466-9-21. ISSN 1471-2466. PMC 2696407. PMID 19445695. Wikidata Q37227589.{{cite journal}}: CS1 maint: unflagged free DOI (link)

References

  1. ^ a b c d "Men of May #14: Prof Novel N Chegou – MOLECULAR BIOLOGY & HUMAN GENETICS NEWS". blogs.sun.ac.za. Retrieved 2022-08-24.
  2. ^ "Chegou". African Scientists Directory. Retrieved 2022-08-24.
  3. ^ a b "News - FMHS' Prof Novel Chegou awarded prestigious..." www.sun.ac.za. Retrieved 2022-08-24.
  4. ^ "TB researcher receives UNESCO-MARS award for emerging talent". www0.sun.ac.za. Retrieved 2022-08-24.
  5. ^ "SAMRC Scientific Merit Silver Award: Profs Chegou and Kinnear – MOLECULAR BIOLOGY & HUMAN GENETICS NEWS". blogs.sun.ac.za. Retrieved 2022-08-24.
  6. ^ SAMRC Merit Awards 2019 - Silver Award - Prof Novel Chegou, retrieved 2022-08-24
  7. ^ "10 Award-Winning Black Scientists You Should Know About". hellobio.com. Retrieved 2022-08-24.
  8. ^ "2018/2019 NSTF-South32 Awards" (PDF).
  9. ^ "Royal Society Africa Prize | Royal Society". royalsociety.org. Retrieved 2022-08-24.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Novel_Njweipi_Chegou&oldid=1138176976"